The Dutch vaccine manufacturer Intravacc BV has appointed Nathalie Laarakker as chief financial officer as the company expands its global manufacturing capacity. Mrs Laarakker joins from the oncology developer Gadeta BV where she was CFO and managing director. She started her professional career at PricewaterhouseCoopers and worked in the firm’s offices in Amsterdam and Boston, US. She has also been head of finance at Merus NV.
Intravacc announced the appointment on 24 March 2021.
Copyright 2021 Evernow Publishing Ltd